These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

744 related items for PubMed ID: 8874342

  • 1. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
    Winick N, Shuster JJ, Bowman WP, Borowitz M, Farrow A, Jacaruso D, Buchanan GR, Kamen BA.
    J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Land VJ, Shuster JJ, Crist WM, Ravindranath Y, Harris MB, Krance RA, Pinkel D, Pullen DJ.
    J Clin Oncol; 1994 Sep; 12(9):1939-45. PubMed ID: 8083715
    [Abstract] [Full Text] [Related]

  • 4. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi AM, Messina C, Mori PG, Miniero R, Colella R, Basso G.
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [Abstract] [Full Text] [Related]

  • 5. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.
    Winick NJ, McKenna RW, Shuster JJ, Schneider NR, Borowitz MJ, Bowman WP, Jacaruso D, Kamen BA, Buchanan GR.
    J Clin Oncol; 1993 Feb; 11(2):209-17. PubMed ID: 8426196
    [Abstract] [Full Text] [Related]

  • 6. Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial.
    Mahoney DH, Shuster J, Nitschke R, Lauer SJ, Winick N, Steuber CP, Camitta B.
    J Clin Oncol; 1998 Jan; 16(1):246-54. PubMed ID: 9440749
    [Abstract] [Full Text] [Related]

  • 7. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
    Mahoney DH, Shuster JJ, Nitschke R, Lauer SJ, Steuber CP, Winick N, Camitta B.
    J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
    [Abstract] [Full Text] [Related]

  • 8. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Lange BJ, Blatt J, Sather HN, Meadows AT.
    Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
    [Abstract] [Full Text] [Related]

  • 9. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH, Camitta BM, Leventhal BG, Shuster JJ, Civin CJ, Ganick DJ, Lauer SJ, Steuber CP, Kamen BA.
    Cancer; 1995 May 15; 75(10):2623-31. PubMed ID: 7736409
    [Abstract] [Full Text] [Related]

  • 10. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F, Suciu S, Philippe N, Benoit Y, Mazingue F, Uyttebroeck A, Lutz P, Mechinaud F, Robert A, Boutard P, Marguerite G, Ferster A, Plouvier E, Rialland X, Behard C, Plantaz D, Dresse MF, Philippet P, Norton L, Thyss A, Dastugue N, Waterkeyn C, Vilmer E, Otten J, Children's Leukemia Cooperative Group of the European Organiztaion for Research and Treatment of Cancer.
    J Clin Oncol; 2001 Apr 01; 19(7):1935-42. PubMed ID: 11283125
    [Abstract] [Full Text] [Related]

  • 11. Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study.
    Mahoney DH, Shuster JJ, Nitschke R, Lauer S, Steuber CP, Camitta B.
    J Clin Oncol; 2000 Mar 01; 18(6):1285-94. PubMed ID: 10715299
    [Abstract] [Full Text] [Related]

  • 12. Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study.
    Camitta B, Mahoney D, Leventhal B, Lauer SJ, Shuster JJ, Adair S, Civin C, Munoz L, Steuber P, Strother D.
    J Clin Oncol; 1994 Jul 01; 12(7):1383-9. PubMed ID: 8021728
    [Abstract] [Full Text] [Related]

  • 13. Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Pullen J, Boyett J, Shuster J, Crist W, Land V, Frankel L, Iyer R, Backstrom L, van Eys J, Harris M.
    J Clin Oncol; 1993 May 01; 11(5):839-49. PubMed ID: 8487048
    [Abstract] [Full Text] [Related]

  • 14. Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study.
    Camitta B, Leventhal B, Lauer S, Shuster JJ, Adair S, Casper J, Civin C, Graham M, Mahoney D, Munoz L.
    J Clin Oncol; 1989 Oct 01; 7(10):1539-44. PubMed ID: 2778483
    [Abstract] [Full Text] [Related]

  • 15. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia.
    Linker C, Damon L, Ries C, Navarro W.
    J Clin Oncol; 2002 May 15; 20(10):2464-71. PubMed ID: 12011123
    [Abstract] [Full Text] [Related]

  • 16. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS, Holdsworth MT, Devidas M, Raisch DW, Chauvenet A, Ravindranath Y, Ducore JM, Amylon MD.
    Pediatr Blood Cancer; 2006 Feb 15; 46(2):179-86. PubMed ID: 16007607
    [Abstract] [Full Text] [Related]

  • 17. Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood.
    Pillon M, Aricò M, Basso G, Locatelli F, Citterio M, Micalizzi C, Testi AM, Barisone E, Nardi M, Lombardi A, Rondelli R, Rosolen A, NHL-Committee of the Italian Association of Pediatric Hematology, Oncology.
    Pediatr Blood Cancer; 2011 Apr 15; 56(4):544-50. PubMed ID: 21298738
    [Abstract] [Full Text] [Related]

  • 18. Methotrexate polyglutamation may lack prognostic significance in children with B-cell precursor acute lymphoblastic leukemia treated with intensive oral methotrexate.
    Mantadakis E, Smith AK, Hynan L, Winick NJ, Kamen BA.
    J Pediatr Hematol Oncol; 2002 Nov 15; 24(8):636-42. PubMed ID: 12439035
    [Abstract] [Full Text] [Related]

  • 19. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
    Marshall GM, Dalla Pozza L, Sutton R, Ng A, de Groot-Kruseman HA, van der Velden VH, Venn NC, van den Berg H, de Bont ES, Maarten Egeler R, Hoogerbrugge PM, Kaspers GJ, Bierings MB, van der Schoot E, van Dongen J, Law T, Cross S, Mueller H, de Haas V, Haber M, Révész T, Alvaro F, Suppiah R, Norris MD, Pieters R.
    Leukemia; 2013 Jul 15; 27(7):1497-503. PubMed ID: 23407458
    [Abstract] [Full Text] [Related]

  • 20. A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial.
    Lauer SJ, Shuster JJ, Mahoney DH, Winick N, Toledano S, Munoz L, Kiefer G, Pullen JD, Steuber CP, Camitta BM.
    Leukemia; 2001 Jul 15; 15(7):1038-45. PubMed ID: 11455971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.